| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $375K | — |
| Cost of Revenue | $20K | — |
| R&D Expense | $91.2M | +73.1% |
| SG&A Expense | $68.8M | +26.8% |
| Operating Income | -$159.6M | -49.3% |
| Interest Expense | $8.2M | — |
| Net Income | -$165.8M | -55.0% |
| EPS (Basic) | -$5.92 | -46.2% |
| EPS (Diluted) | -$5.92 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193.7M | -16.8% |
| Accounts Receivable | $248K | — |
| Inventory | $2.0M | — |
| Current Assets | $202.9M | -14.3% |
| Total Assets | $205.9M | -14.0% |
| Current Liabilities | $32.9M | +97.4% |
| Long-term Debt | $93.1M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.3M | -64.7% |
| Capital Expenditures | $139K | -68.8% |
| Investing Cash Flow | -$139K | +68.8% |
| Financing Cash Flow | $96.2M | -6.1% |
| Free Cash Flow | -$135.5M | -64.0% |
| -46.2% |
| Total Liabilities |
| $129.1M |
| +626.3% |
| Stockholders' Equity | $76.8M | -65.4% |